Terms: = Pancreatic cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12
424 results:
1. A Comparison of Spatial and Phenotypic Immune Profiles of pancreatic Ductal Adenocarcinoma and Its Precursor Lesions.
Enzler T; Shi J; McGue J; Griffith BD; Sun L; Sahai V; Nathan H; Frankel TL
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474199
[TBL] [Abstract] [Full Text] [Related]
2. Exploring genetic associations of Crohn's disease and ulcerative colitis with extraintestinal cancers in European and East Asian populations.
Yu C; Xu J; Xu S; Tang L; Han Q; Zeng X; Huang Y; Yu T; Sun Z
Front Immunol; 2024; 15():1339207. PubMed ID: 38404590
[TBL] [Abstract] [Full Text] [Related]
3. Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis.
Chen Y; Zhang F; Zhang B; Trojanowicz B; Hämmerle M; Kleeff J; Sunami Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1990. PubMed ID: 38389400
[TBL] [Abstract] [Full Text] [Related]
4. Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Khachfe HH; Hammad AY; AlMasri S; Nassour I; ElAsmar R; Liu H; de Silva A; Kraftician J; Lee KK; Zureikat AH; Paniccia A
J Surg Oncol; 2024 May; 129(6):1097-1105. PubMed ID: 38316936
[TBL] [Abstract] [Full Text] [Related]
5. Causal linkage between type 2 diabetes mellitus and inflammatory bowel disease: an integrated Mendelian randomization study and bioinformatics analysis.
Xiao X; Wu X; Yi L; You F; Li X; Xiao C
Front Endocrinol (Lausanne); 2024; 15():1275699. PubMed ID: 38313367
[TBL] [Abstract] [Full Text] [Related]
6. Proctoring System Enables Safe Induction of Robotic Gastrectomy: Short-term Outcomes of the First 10 Cases.
Takahashi N; Takano Y; Takeshita K; Toya N; Yano F; Eto K
Anticancer Res; 2024 Feb; 44(2):823-828. PubMed ID: 38307575
[TBL] [Abstract] [Full Text] [Related]
7. Risk factors for abdominal surgical infectious complications after distal gastrectomy for gastric cancer: A post-hoc analysis of a randomized controlled trial (JCOG0912).
Taki Y; Ito S; Mizusawa J; Yura M; Sato Y; Nomura T; Tsuda M; Omori T; Kunisaki C; Choda Y; Cho H; Hiki N; Boku N; Yoshikawa T; Katai H; Terashima M
Eur J Surg Oncol; 2024 Mar; 50(3):107982. PubMed ID: 38290246
[TBL] [Abstract] [Full Text] [Related]
8. Neoadjuvant chemotherapy-induced remodeling of human hormonal receptor-positive breast cancer revealed by single-cell RNA sequencing.
Jia F; Sun S; Li J; Wang W; Huang H; Hu X; Pan S; Chen W; Shen L; Yao Y; Zheng S; Chen H; Xia W; Yuan H; Zhou J; Yu X; Zhang T; Zhang B; Huang J; Ni C
Cancer Lett; 2024 Mar; 585():216656. PubMed ID: 38266804
[TBL] [Abstract] [Full Text] [Related]
9. Altered DNA methylation within DNMT3A, AHRR, LTA/TNF loci mediates the effect of smoking on inflammatory bowel disease.
Zhang H; Kalla R; Chen J; Zhao J; Zhou X; Adams A; Noble A; Ventham NT; Wellens J; Ho GT; Dunlop MG; Nowak JK; Ding Y; Liu Z; Satsangi J; Theodoratou E; Li X
Nat Commun; 2024 Jan; 15(1):595. PubMed ID: 38238335
[TBL] [Abstract] [Full Text] [Related]
10. MNX1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive Breast cancer.
Chi W; Xiu B; Xiong M; Wang X; Li P; Zhang Q; Hou J; Sang Y; Zhou X; Chen M; Zheng S; Zhang L; Xue J; Chi Y; Wu J
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203393
[TBL] [Abstract] [Full Text] [Related]
11. An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer.
Mahadevia H; Uson Junior PLS; Wang J; Borad M; Babiker H
Expert Opin Pharmacother; 2024; 25(1):79-90. PubMed ID: 38193476
[TBL] [Abstract] [Full Text] [Related]
12. DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation.
Yan J; Wang S; Zhang J; Yuan Q; Gao X; Zhang N; Pan Y; Zhang H; Liu K; Yu J; Lu L; Liu H; Gao X; Zhao S; Zhang W; Reyila A; Qi Y; Zhang Q; Cang S; Lu Y; Pan Y; Kong Y; Nie Y
Cancer Biol Med; 2023 Dec; 21(3):252-66. PubMed ID: 38164720
[TBL] [Abstract] [Full Text] [Related]
13. pancreatic resection for metastasis from renal cell carcinoma: A single institution experience and meta-analysis of survival outcomes.
Hajibandeh S; Hajibandeh S; Romman S; Ghassemi N; Evans D; Laing RW; Durkin D; Athwal TS
Pancreatology; 2024 Feb; 24(1):160-168. PubMed ID: 38012888
[TBL] [Abstract] [Full Text] [Related]
14. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
Huang Y; Gong P; Su L; Zhang M
Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210
[TBL] [Abstract] [Full Text] [Related]
15. Bioinformatics identification of a T-cell-related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma.
Wang D; Ding D; Ying J; Qin Y
IET Syst Biol; 2023 Dec; 17(6):366-377. PubMed ID: 37935646
[TBL] [Abstract] [Full Text] [Related]
16. Toxic mechanisms of cadmium and exposure as a risk factor for oral and gastrointestinal carcinomas.
Tavakoli Pirzaman A; Ebrahimi P; Niknezhad S; Vahidi T; Hosseinzadeh D; Akrami S; Ashrafi AM; Moeen Velayatimehr M; Hosseinzadeh R; Kazemi S
Hum Exp Toxicol; 2023; 42():9603271231210262. PubMed ID: 37870872
[TBL] [Abstract] [Full Text] [Related]
17. Case Report: Durable complete response of metastatic hepatocellular carcinoma with asymptomatic hyperamylasemia to combined immunotherapy of anti-cytotoxic T lymphocyte-associated antigen 4 plus anti-programmed cell death-1 antibodies.
Gao H; Chang RZ; Chen XP; Zhang WG; Zhang B; Luo X; Ding ZY
Front Immunol; 2023; 14():1274449. PubMed ID: 37869012
[TBL] [Abstract] [Full Text] [Related]
18. In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases.
Kerzel T; Giacca G; Beretta S; Bresesti C; Notaro M; Scotti GM; Balestrieri C; Canu T; Redegalli M; Pedica F; Genua M; Ostuni R; Kajaste-Rudnitski A; Oshima M; Tonon G; Merelli I; Aldrighetti L; Dellabona P; Coltella N; Doglioni C; Rancoita PMV; Sanvito F; Naldini L; Squadrito ML
Cancer Cell; 2023 Nov; 41(11):1892-1910.e10. PubMed ID: 37863068
[TBL] [Abstract] [Full Text] [Related]
19. Overexpression of SH2D1A promotes cancer progression and is associated with immune cell infiltration in hepatocellular carcinoma via bioinformatics and in vitro study.
Xiang QM; Jiang N; Liu YF; Wang YB; Mu DA; Liu R; Sun LY; Zhang W; Guo Q; Li K
BMC Cancer; 2023 Oct; 23(1):1005. PubMed ID: 37858067
[TBL] [Abstract] [Full Text] [Related]
20. S100P as a potential biomarker for immunosuppressive microenvironment in pancreatic cancer: a bioinformatics analysis and in vitro study.
Hao W; Zhang Y; Dou J; Cui P; Zhu J
BMC Cancer; 2023 Oct; 23(1):997. PubMed ID: 37853345
[TBL] [Abstract] [Full Text] [Related]
[Next]
